Health Care Equipment & Services

Insider selling spikes at PACS Group—chief accountants liquidate nearly $470K in shares above the market price, hinting at possible strategic shifts or cash needs.

Insightful breakdown of CEO Atay Oguzhan’s recent insider trades at BillionToOne – a disciplined Rule 10b5‑1 buy‑sell strategy that keeps ownership neutral while boosting liquidity and showing confidence in the company’s growth.

ACME United insider moves reveal a balanced “buy low, sell high” strategy—Susan Murphy sells at a 52‑week peak, adds shares at a lower exercise price, signaling confidence and long‑term growth in the health‑care supply chain.

Inside BillionToOne’s recent Class A share moves, see how insider buying, selling, and non‑consideration transfers signal management confidence and investor implications.

Castle Biosciences insider sales reveal a disciplined cash‑management strategy, not a red flag, and suggest confidence in the company’s rising valuation.

NEOGEN insider trade: Gregory S. buys 1,211 shares, sells 337, and offloads 1,211 RSUs—showing confidence amid a volatile, 52‑week low stock.

NEOGEN insider buying surge: execs buy 1,776 shares amid product pipeline buzz—what it means for investors and stock value.

Insider buying at NEOGEN Corp. signals confidence amid price swings, suggesting the diagnostic firm may be undervalued and poised for a rebound.

Insider sales and buys show NEOGEN’s leadership balancing liquidity with confidence—an insider‑driven hint of possible upside amid a 4.5% weekly dip.

Acme United’s insider buys reveal strategic confidence amid a medical expansion and My Medic acquisition, offering investors insight into future growth opportunities.